
[ Thu, Dec 27th 2018 ]: WOPRAI

[ Wed, Dec 26th 2018 ]: WOPRAI

[ Fri, Dec 21st 2018 ]: WOPRAI
[ Fri, Dec 21st 2018 ]: WOPRAI
[ Fri, Dec 21st 2018 ]: WOPRAI
[ Fri, Dec 21st 2018 ]: WOPRAI
[ Fri, Dec 21st 2018 ]: WOPRAI
[ Fri, Dec 21st 2018 ]: WOPRAI
[ Fri, Dec 21st 2018 ]: WOPRAI
[ Fri, Dec 21st 2018 ]: WOPRAI
[ Fri, Dec 21st 2018 ]: WOPRAI
[ Fri, Dec 21st 2018 ]: WOPRAI
[ Fri, Dec 21st 2018 ]: WOPRAI

[ Thu, Dec 20th 2018 ]: WOPRAI
[ Thu, Dec 20th 2018 ]: WOPRAI
[ Thu, Dec 20th 2018 ]: WOPRAI
[ Thu, Dec 20th 2018 ]: WOPRAI
[ Thu, Dec 20th 2018 ]: WOPRAI
[ Thu, Dec 20th 2018 ]: WOPRAI
[ Thu, Dec 20th 2018 ]: WOPRAI

[ Wed, Dec 19th 2018 ]: WOPRAI
[ Wed, Dec 19th 2018 ]: WOPRAI
[ Wed, Dec 19th 2018 ]: WOPRAI
[ Wed, Dec 19th 2018 ]: WOPRAI
[ Wed, Dec 19th 2018 ]: WOPRAI
[ Wed, Dec 19th 2018 ]: WOPRAI
[ Wed, Dec 19th 2018 ]: WOPRAI
[ Wed, Dec 19th 2018 ]: WOPRAI
[ Wed, Dec 19th 2018 ]: WOPRAI
[ Wed, Dec 19th 2018 ]: WOPRAI
[ Wed, Dec 19th 2018 ]: WOPRAI

[ Tue, Dec 18th 2018 ]: WOPRAI
[ Tue, Dec 18th 2018 ]: WOPRAI
[ Tue, Dec 18th 2018 ]: WOPRAI
[ Tue, Dec 18th 2018 ]: WOPRAI
[ Tue, Dec 18th 2018 ]: WOPRAI
[ Tue, Dec 18th 2018 ]: WOPRAI
[ Tue, Dec 18th 2018 ]: WOPRAI
[ Tue, Dec 18th 2018 ]: WOPRAI
[ Tue, Dec 18th 2018 ]: WOPRAI
[ Tue, Dec 18th 2018 ]: WOPRAI

[ Mon, Dec 17th 2018 ]: WOPRAI
[ Mon, Dec 17th 2018 ]: WOPRAI
[ Mon, Dec 17th 2018 ]: WOPRAI
[ Mon, Dec 17th 2018 ]: WOPRAI
[ Mon, Dec 17th 2018 ]: WOPRAI
[ Mon, Dec 17th 2018 ]: WOPRAI
[ Mon, Dec 17th 2018 ]: WOPRAI
Matthew Harrison Maintained (VRTX) at Buy with Decreased Target to $210 on, Dec 19th, 2018


🞛 This publication is a summary or evaluation of another publication
Matthew Harrison of Morgan Stanley, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Decreased Target from $211 to $210 on, Dec 19th, 2018.
Matthew has made no other calls on VRTX in the last 4 months.
There are 3 other peers that have a rating on VRTX. Out of the 3 peers that are also analyzing VRTX, 0 agree with Matthew's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Matthew
- Andrew Fein of "HC Wainwright & Co." Upgraded from Hold to Strong Buy and Held Target at $220 on, Friday, October 26th, 2018
- Christopher Raymond of "Raymond James" Maintained at Buy with Decreased Target to $201 on, Thursday, October 25th, 2018
- Do Kim of "BMO Capital" Maintained at Buy with Decreased Target to $192 on, Thursday, October 25th, 2018
Similar Stocks and Investing Publications
[ Tue, Dec 04th 2018 ]: WOPRAI
[ Tue, Oct 30th 2018 ]: WOPRAI
[ Fri, Oct 26th 2018 ]: WOPRAI
[ Wed, May 02nd 2018 ]: WOPRAI
[ Wed, Apr 25th 2018 ]: WOPRAI
[ Mon, Feb 05th 2018 ]: WOPRAI
[ Wed, Jan 31st 2018 ]: WOPRAI
[ Fri, Jan 26th 2018 ]: WOPRAI
[ Wed, Jan 24th 2018 ]: WOPRAI
[ Fri, Nov 18th 2016 ]: WOPRAI
[ Mon, Feb 01st 2016 ]: WOPRAI
[ Fri, Oct 30th 2015 ]: WOPRAI